Grant Pre-Review Form, 2015
Department of Immunology
contact: Lisa Borghesi, Chair of Pre-Review Committee
[email protected]; 412.383.7074
Instructions for PI:
Submission Deadline: submit your Specific Aims at least 6 weeks prior to NIH due date.
Turnaround Time: The committee will provide you with critiques ~7 business days after assignment to reviewers.
A0 submissions: paste your Specific Aims on the next page and email to [email protected].
A1 submissions: paste your (1) Specific Aims and (2) Response to Critiques (a draft bullet point response is sufficient) on the next page; (3) append the Summary Statement. Email to [email protected].
Application Title:
NIH Award Mechanism (select type): ___ R01-A0 ___ R01-A1 ___ R21-A0 ___ R21-A1
For A1 submissions: Summary Statement and Response to Critiques both attached? ____ yes
Targeted Study Section:
NIH Submission Deadline (mm/dd/yy):
Preferred Reviewers (prioritize 4 names from below expertise; you will receive 2 formal reviews):
John Alcorn – IHD, Virology & Immunology/Vaccines SEP Per Basse – NCI P01, DOD Ira Bergman – pediatric neurology Robert Binder – CMI-A, NCI provocative questions SEP Lisa Borghesi – CMI-B Lisa Butterfield – CII Kelly Cole – AIDS, SBIR, Emerging Infectious Dis. SEP Abbe de Vallejo – HAI, ASG Bob Ferris – TME Olja Finn – TTT Joanne Flynn – HIBP, vaccine & immunity to infections Sarah Gaffen – IHD Bob Hendricks – VIR-B, VIS-A Pawel Kalinksi – CONC, CII, ICMIC and cancer SEPs Larry Kane – CMI-A, CMI-B, MIST, TTT William Klimstra – VIR-A, VIR-B, DOD/DTRA vacc & therap |
Michael Lotze – Clinical Oncology, Innovation NIH Binfeng Lu – DOD-Multiple Sclerosis Chris Milcarek – CMI-A, Biochemistry Diana Metes – NHLBI, NSF, AHA Penny Morel – III, HAI, IHD Jon Piganelli – NIDDK Innov. Partnerships in Type I Diabetes David Rothstein – TTT Kate Ryman – VMD Walt Storkus – TTT, CII, TME Mark Shlomchik – CMI-B Dario Vignali – CMI-A Anda Vlad – CII Yoram Vodovotz – systems/computational biology Simon Watkins – MI, often Chair on imaging panels Hassane Zarour – TME, SBIR
|
Instructions for Reviewer: Please return your critiques within 7 business days to [email protected].
Reviewer name:
Overall Impact Score (see table for guidance):
Impact |
Score |
|
Strengths |
Weaknesses |
High Impact |
1 |
Exceptional |
Exceptionally strong |
Essentially no weaknesses |
2 |
Outstanding |
Extremely strong |
Negligible weaknesses |
|
3 |
Excellent |
Very strong |
Only some minor weaknesses |
|
Moderate Impact |
4 |
Very Good |
Strong |
Numerous minor weaknesses |
5 |
Good |
Strong |
At least one moderate weakness |
|
6 |
Satisfactory |
Some strengths |
Some moderate weaknesses |
|
Low Impact |
7 |
Fair |
Some strengths |
At least one major weakness |
8 |
Marginal |
A few strengths |
A few major weaknesses |
|
9 |
Poor |
Very few strengths |
Numerous major weaknesses |
Write comments here and/or track changes directly on next pages. |
For A0 submissions paste Specific Aims here.
For A1 submissions paste Specific Aims and Response to Critiques here; append Summary Statement.
modified 032115
CULTURAL GRANTS SUCCESSFUL RECIPIENTS 201516 APPLICANT CATEGORY
DELIVERING COMMUNITY SERVICES IN PARTNERSHIP GRANT AGREEMENT
Maxine Sevack Memorial Grant 500 a Scholarship Fund
Tags: prereview, department, grant, immunology, contact